VIRCA NICHOLAS J 4
4 · Inhibitor Therapeutics, Inc. · Filed Dec 28, 2020
Insider Transaction Report
Form 4
VIRCA NICHOLAS J
DirectorPresident and CEO
Transactions
- Award
Common Stock Option
2020-12-22+125,000→ 125,000 totalExercise: $0.03From: 2020-12-22Exp: 2030-12-22→ Common Stock (125,000 underlying)